The global nanorobotics market size reached US$ 6.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.1 Billion by 2028, exhibiting a growth rate (CAGR) of 11.1% during 2023-2028.
Nanorobotics refers to an emerging technology that helps to create machines or robots that have components around the scale of a nanometer. These robots are known as nanorobots and can be injected into patients for performing diagnosis or providing treatment at the cellular level. They can also be used in pharmacokinetics, disease monitoring, targeting drug delivery in cancer therapeutics and improving the effectiveness and efficiency of healthcare. Besides this, they are utilized for assembling and maintaining sophisticated systems.
Extensive applications of nanorobotics in the medical industry are one of the primary factors driving the market growth. Recent research has suggested that nanorobots can serve as antibodies or antiviral agents in patients with compromised immunity or diseases that do not respond to conventional treatment methods. As a result, nanorobots are being used in gene therapy and cancer detection and treatment. They are also being employed in various dentistry procedures and act as ancillary devices for processing different chemical reactions in the affected organs. Furthermore, nanorobots are utilized for monitoring and controlling glucose levels in diabetic patients. Some of the other medical applications of nanorobots that are strengthening the nanorobotics market growth include repairing damaged tissues and unblocking arteries affected by plaques. Apart from this, governments of several countries are extending their support by increasing investments in nanorobotics. Consequently, the leading players are increasing their focus on research and development (R&D) activities to introduce technological advancements in molecular robotics.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global nanorobotics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, application and end user.
Breakup by Type:
Bacteria Powered Nanobots
Breakup by Application:
Health Sensors and Replicators
Breakup by End User:
Breakup by Region:
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being Bruker Corporation, EV Group, Ginkgo Bioworks Inc., Imina Technologies SA, JEOL Ltd., Kleindiek Nanotechnik GmbH, Nanonics Imaging Limited, Oxford Instruments plc, Synthace Limited, Thermo Fisher Scientific Inc., Toronto Nano Instrumentation Inc. and Zymergen Inc.
Base Year of the Analysis
Type, Application, End User, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Bruker Corporation, EV Group, Ginkgo Bioworks Inc., Imina Technologies SA, JEOL Ltd., Kleindiek Nanotechnik GmbH, Nanonics Imaging Limited, Oxford Instruments plc, Synthace Limited, Thermo Fisher Scientific Inc., Toronto Nano Instrumentation Inc. and Zymergen Inc.
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global nanorobotics market was valued at US$ 6.4 Billion in 2022.
We expect the global nanorobotics market to exhibit a CAGR of 11.1% during 2023-2028.
The rising demand for nanorobotics in the medical industry as they aid in targeting drug delivery in cancer therapeutics, enabling early disease diagnosis, providing better treatment at a cellular level, etc., is primarily driving the global nanorobotics market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing adoption of nanorobots to serve as antibodies or antiviral agents in coronavirus-infected patients with compromised immunity or those who do not respond to conventional treatment methods.
Based on the application, the global nanorobotics market can be segmented into medical imaging, information storage, drug delivery, health sensors and replicators, and others. Currently, drug delivery accounts the majority of the largest market share.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global nanorobotics market include Bruker Corporation, EV Group, Ginkgo Bioworks Inc., Imina Technologies SA, JEOL Ltd., Kleindiek Nanotechnik GmbH, Nanonics Imaging Limited, Oxford Instruments plc, Synthace Limited, Thermo Fisher Scientific Inc., Toronto Nano Instrumentation Inc., and Zymergen Inc.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.